Global Highlights first half 2016/17
SomnoMed
• Global MAS sales volumes +14.9%; group revenues +11.5%
- Good acceleration in Australia in second quarter
- Consistent strong growth in Europe
- Lower growth in the US linked to RSS launch
• MAS gross margin improved from 68.5% to 69.3% with group gross margin up to 57.7%
• EBITDA up 57% to $1.4m (excluding RSS)
Renew Sleep Solutions (“RSS”)
• First two centres opened in December 2016 and ahead of plan
• Investment and start up cost below model assumptions
• Initial revenues and costs in line with expectations
To view Presentation please download PDF attached:
Download this document
